Your genetic profile in these pathways may inform expectations around initial response speed, plateau patterns, and long-term weight loss ceiling
Luminal infusion of the bile acid chenodeoxycholic acid, in rats, triggers release of GLP-1 into the vasculature, in addition to PYY, via TGR5 (Kuhre et al., 2018)
Here is a simple breakdown based on the 6-day half-life: After 6 days, 50% of the dose remains After 12 days, 25% remains After 18 days, 12.5% remains After 24 days, about 6% remains After 30 days, less than 4% remains In practice, most pharmacologists consider a drug effectively cleared after 5 half-lives
in fact, among those who do start using GLP-1s, over 50% stop due to costs, and as many as 36% stop due to side effects
Publisher | Google Scholor Ganamurali N, Sabarathinam S